Oaktree Acquisition Corp III Life Sciences Warrant
OACCW
29 hedge funds and large institutions have $2.09M invested in Oaktree Acquisition Corp III Life Sciences Warrant in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 7 reducing their positions, and closing their positions.
12% more funds holding
Funds holding: 26 → 29 (+3)
1.56% more ownership
Funds ownership: 73.41% → 74.97% (+1.6%)
4% less capital invested
Capital invested by funds: $2.19M → $2.09M (-$98.2K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
+$88.4K |
| 2 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$54.1K |
| 3 |
DAM
DLD Asset Management
New York
|
+$37.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$88.4K |
| 2 |
DAM
Decagon Asset Management
London,
United Kingdom
|
-$37.7K |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$4.33K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$873 |
| 5 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$800 |
OACCW Hedge Fund Activity: Q4 2025 in Review
29 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) for Q4 2025, worth a combined $2.09M — down 4.5% from $2.19M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new OACCW positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 7 trimmed.
The largest buyer was BNP Paribas Financial Markets, opening a new position worth an estimated $88.4K. The largest seller was AQR Arbitrage, cutting an estimated $88.4K.
- 29 institutional investors held Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) as of Q4 2025, up from 26 in Q3 2025.
- Funds reported $2.09M of Oaktree Acquisition Corp III Life Sciences Warrant stock for Q4 2025, down 4.5% quarter-over-quarter.
- 3 funds opened new Oaktree Acquisition Corp III Life Sciences Warrant positions in Q4 2025 and 0 closed out, a net change of +3 holders.
- The largest Oaktree Acquisition Corp III Life Sciences Warrant buyer in Q4 2025 was BNP Paribas Financial Markets, an estimated $88.4K added.
- The largest Oaktree Acquisition Corp III Life Sciences Warrant seller in Q4 2025 was AQR Arbitrage, an estimated $88.4K sold.
Based on aggregated 13F filings for Q4 2025.